Kolinpharma is pleased to announce the renewal of its strategic collaboration with La Neurologia Italiana, a journal published by MeP Edizioni (Doctor and Patient), dedicated to the ongoing education, information, and training of neurologists and related professionals.

This partnership reflects the company's vision of nutraceuticals based on solid evidence and ongoing dialogue with the medical community. By supporting such a high-profile journal, Kolinpharma reaffirms its commitment to promoting the dissemination of quality scientific content, clinical studies, and therapeutic insights that support specialists in their daily practice.

The pillars of the collaboration:

• Medical Update (CME): Support for the dissemination of new guidelines and cutting-edge protocols in neuroscience.
• Research and Development: Sharing clinical evidence regarding Kolinpharma's patents and innovative formulations for nervous system health.
• Scientific Dialogue: Strengthening the link between biochemical innovation and specialized clinical application.

The renewal of this synergy confirms Kolinpharma's role as a strategic partner for Italian Neurology, combining a passion for research with the need for rigorous, ethical, and constantly updated medical information.